 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Arch Therapeutics stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy OTC:ARTH! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Arch Therapeutics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.
Average volume
363,192 shs
MARKET CAP
$32.83 million
Stock exchange
OTCMKTS
Buy this stock!
|
NAME
|
TICKER
|
INDUSTRY
|
SECTOR
|
VOLUME
|
BUY THIS STOCK NOW
|
|---|---|---|---|---|---|
|
Arch Therapeutics
|
OTCMKTS:ARTH
|
Surgical & medical instruments
|
Medical
|
257,500 shs
|
Below is a quick guide on how to buy OTC:ARTH stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Arch Therapeutics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Arch Therapeutics – Search for “”OTC:ARTH”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Arch Therapeutics stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Arch Therapeutics in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Arch Therapeutics stock.
Wall Street analysts have given Arch Therapeutics a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Arch Therapeutics wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing OTC:ARTH stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Arch Therapeutics stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Arch Therapeutics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “OTC:ARTH stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some OTC:ARTH stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, OTC:ARTH is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Arch Therapeutics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Arch Therapeutics, Inc. (OTCMKTS:ARTH) announced its quarterly earnings results on Thursday, July, 23rd. The biotechnology company reported ($0.01) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.01.
View Arch Therapeutics’ earnings history.
Arch Therapeutics’ stock was trading at $0.2050 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ARTH shares have decreased by 17.1% and is now trading at $0.17.
2 brokers have issued twelve-month price objectives for Arch Therapeutics’ shares. Their forecasts range from $1.25 to $1.50. On average, they expect Arch Therapeutics’ share price to reach $1.38 in the next year. This suggests a possible upside of 708.8% from the stock’s current price.
View analysts’ price targets for Arch Therapeutics or view top-rated stocks among Wall Street analysts.
Arch Therapeutics’ management team includes the following people:
Dr. Terrence W. Norchi, Co-Founder, Chairman, Pres, CEO & Sec. (Age 55, Pay $519.2k)
Mr. Richard E. Davis, CFO & Treasurer (Age 62, Pay $387.26k)
Dr. Rutledge Ellis-Behnke Ph.D., Co-Founder & Scientific Advisor
Dr. Steven A. Kates, VP of Technology
Dr. Elaine Whitmore, Regulatory Consultant & Advisor
Dr. Avtar S. Dhillon, Bus. Advisor (Age 59)
Mr. Daniel C. Wadsworth Jr., Advisor & Consultant of Wound Care Commercialization (Age 66)
Dr. Dmitry Nepomnayshy, Clinical Advisor
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying OTC:ARTH stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Some companies that are related to Arch Therapeutics include Beyond Air (XAIR), Apollo Endosurgery (APEN), Spectral Medical (EDTXF), Pro-Dex (PDEX), Venus Concept (VERO), Brainsway (BWAY), SANUWAVE Health (SNWV), Delcath Systems (DCTH), LENSAR (LNSR), Nephros (NEPH), Sensus Healthcare (SRTS), AIT Therapeutics (AITB), STRATA Skin Sciences (SSKN), Nephros (NEPHD) and Sintx Technologies (SINT).
View all of ARTH’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Arch Therapeutics investors own include Anavex Life Sciences (AVXL), POET Technologies (POETF), Aptose Biosciences (APTO), Inovio Pharmaceuticals (INO), Actinium Pharmaceuticals (ATNM), SCYNEXIS (SCYX), Bellerophon Therapeutics (BLPH), Sorrento Therapeutics (SRNE), Biocept (BIOC) and Aurinia Pharmaceuticals (AUPH).
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Arch Therapeutics trades on the OTCMKTS under the ticker symbol “ARTH.”
Shares of ARTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
One share of ARTH stock can currently be purchased for approximately $0.17.
Arch Therapeutics has a market capitalization of $32.83 million.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Arch Therapeutics employs 7 workers across the globe.
The official website for Arch Therapeutics is www.archtherapeutics.com.
Arch Therapeutics is headquartered at 235 WALNUT STREET SUITE 6, FRAMINGHAM MA, 01702.
Arch Therapeutics’ mailing address is 235 WALNUT STREET SUITE 6, FRAMINGHAM MA, 01702. The biotechnology company can be reached via phone at 617-431-2313 or via email at investors@archtherapeutics.com
At reportlab we want to help you with a detailed stock analysis, we want to remind you that the data provided on this website is not necessarily entirely current or accurate. The data and quotes on the website are not always provided by a market or exchange, but may also come from market makers. Therefore, the quotes may not be accurate and may differ from the actual price on a market. They are indicative quotes and are not suitable for trading purposes.
At Reportlab.org we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy Arch Therapeutics?
The safest and easiest way to buy OTC:ARTH is by using a regulated broker like eToro. You can open an account with the platform, make a deposit and buy this investment all in under 5 minutes from start to finish.
Another option is using a regulated exchange like Binance or Coinbase. You can open an account with these exchanges and start buying or trading. ?
Where to buy Arch Therapeutics stock?
You will first want to find a licensed broker that supports OTC:ARTH stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading OTC:ARTH stocks in a safe and complete environment.
Is OTC:ARTH stock a good investment?
As with any other asset, there is an element of risk associated with buying OTC:ARTH stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Arch Therapeutics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with OTC:ARTH is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Arch Therapeutics stock.
How do you trade Arch Therapeutics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Arch Therapeutics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on OTC:ARTH stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Arch Therapeutics stock?
To sell your OTC:ARTH stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Arch Therapeutics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading OTC:ARTH stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
| |
Our score |
0% commission |
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
Reportlab Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 Reportlab.Finance | All rights reserved.
-logo.jpg){kind=logo}
-logo.jpg){kind=logo}
-logo.jpg){kind=logo}
“”
-logo.jpg){kind=logo}
-logo.jpg){kind=logo}
-logo.jpg){kind=logo}
-logo.jpg){kind=logo}
“”
-logo.jpg){kind=logo}
-logo.jpg){kind=logo}
-logo.png){kind=logo}
-logo.png){kind=logo}
-logo.jpg){kind=logo}
-logo.jpg){kind=logo}
-logo.png){kind=logo}
